跳至主要内容
临床试验/NCT04734912
NCT04734912Unknown不适用

Evaluation of Transnasal Endoscopy During COVID-19 Pandemic

Johannes Gutenberg University Mainz2 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2021年1月13日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
500
试验地点
2
主要终点
Questionnaire

研究概览

简要总结

Patients who received the indication for endoscopic diagnostics using gastroscopy in transnasal technique will be included into the study. The examination is carried out in standard technique and is not influenced by the study. Following the examination, patient data is collected pseudonymously and a questionnaire is submitted to the patient.

详细描述

COVID-19 is transmitted, among other things, by a droplet infection. Conventional gastroscopy through the patient's mouth is therefore considered a high-risk examination for the medical and nursing staff. Alternatively, gastroscopy can also be performed through the patient's nose. An advantage here is that the aerosol formation is naturally significantly reduced and the patient usually does not need sedation, since in transnasal endoscopy no stranglehold occurs. Transnasal endoscopy therefore appears to us, especially during the COVID-19 pandemic, as a safe alternative to conventional gastroscopy.

Patients who received the indication for endoscopic diagnostics using gastroscopy in transnasal technique will be included into the study. The examination is carried out in standard technique and is not influenced by the study. Following the examination, patient data is collected pseudonymously and a questionnaire is sumbitted to the patient.

Only patients who have the indication for gastroscopy in transnasal technique are included. A specific risk to patients cannot be foreseen.This study does not interfere with diagnostics or therapy.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Indication for transnasal endoscopy

排除标准

  • pregnancy
  • breast feeding
  • contraindication to transnasal endoscopy
  • pronounced blood clotting disorders

结局指标

主要结局

Questionnaire

时间窗: after examination, about 15 minutes

a questionnaire with 5 questions regarding the quality of the examination, technique and safety is presented to the patients

次要结局

未报告次要终点

研究者

发起方
Johannes Gutenberg University Mainz
申办方类型
Other
责任方
Principal Investigator
主要研究者

Prof. Helmut Neumann

Principal Investigator

Johannes Gutenberg University Mainz

研究点 (2)

Loading locations...

相似试验

Evaluation of Transnasal Endoscopy During COVID-19... | 临床试验